Study Title
SEPTRALU, Spanish Series of Patients Treated With the Radionuclide Lutetium177
Study Details
Description:
This study aims to pool the clinical experience of Spanish centers treating patients with 177Lu-DOTATATE to evaluate the efficacy, tolerance, and safety of the drug in routine clinical practice and to learn about the profiles of patients and tumors treated and the results in each type of patient and tumor.
Sponsor:
Sociedad Española de Medicina Nuclear e Imagen Molecular
Contacts:
Mercedes Dr Mitjavila Casanovas, MD-PhD (Principal Investigator)mercedes.mitjavila@salud.madrid.org
911916000 ext 46261
Paula Dr Jiménez Fonseca, MD-PhDpalucaji@hotmail.com
985106121 ext 36582
Government Study Link:
NCT04949282 - Click here to see study onClinicalTrials.gov
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468